EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The role of clonal progression leading to the development of therapy-related myeloid neoplasms

Luca Guarnera, Maria Rosaria Pascale, Hajro Hajrullaj, Antonio Cristiano, Flavia Mallegni, Angelo Onorato, Maria Teresa Voso, Emiliano Fabiani

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05803-y ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Annals of Hematology, 2024. Verfasst von Luca Guarnera und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Ital…. Hauptthemen laut MEDLINE: Mutation, Neoplasms, Second Primary. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapy-related myeloid neoplasms (t-MN) are characterized by aggressive features and a dismal prognosis. Recent evidence suggests a higher incidence of t-MN in individuals harboring clonal hematopoiesis of indeterminate potential (CHIP). In order to gain insight into CHIP-driven malignant progression, we gathered data from ten published reports with available detailed patient characteristics at the time of primary malignancy and t-MN development. Detailed clinical and molecular information on primary malignancy and t-MN were available for 109 patients: 43% harbored at least one somatic mutation at the time of the primary malignancy. TET2 and TP53 mutations showed an increasing variant allele frequency from CHIP to t-MN. ASXL1 -associated CHIP significantly correlated with the emergence of TET2 and CEBPA mutations at t-MN, as well as U2AF1 -driven CHIP with EZH2 mutation and both IDH2 and SRSF2 -driven CHIP with FLT3 mutation. DNMT3A -driven CHIP correlated with a lower incidence of TP53 mutation at t-MN. In contrast, TP53 -driven CHIP correlated with a complex karyotype and a lower tendency to acquire new mutations at t-MN. Patients with multiple myeloma as their first malignancy presented a significantly higher rate of TP53 mutations at t-MN. The progression from CHIP to t-MN shows different scenarios depending on the genes involved. A deeper knowledge of CHIP progression mechanisms will allow a more reliable definition of t-MN risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MutationNeoplasms, Second PrimaryAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedClonal HematopoiesisDisease ProgressionMyeloproliferative Disorders

Stichwörter der Autor:innen

Clonal Hematopoiesis of Indeterminate PotentialMyeloid neoplasms post cytotoxic therapyTP53Therapy-related Myeloid Neoplasms

Autor:innen und Institutionen

  • Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy.
  • Department of Translational Hematology & Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, 44114, USA.
  • Transfusion Medicine Unit, Cardarelli Hospital, 86100, Campobasso, Italy.
  • Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Department of Biomedicine and Prevention, PhD in Medical-Surgical Biotechnologies and Translational Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. voso@med.uniroma2.it.

Zitieren

APA

Guarnera, L., Pascale, M. R., Hajrullaj, H., Cristiano, A., Mallegni, F., Onorato, A., Voso, M. T., & Fabiani, E. (2024). The role of clonal progression leading to the development of therapy-related myeloid neoplasms. Annals of Hematology. https://doi.org/10.1007/s00277-024-05803-y

Vancouver

Guarnera L, Pascale MR, Hajrullaj H, Cristiano A, Mallegni F, Onorato A, et al. The role of clonal progression leading to the development of therapy-related myeloid neoplasms. Annals of Hematology. 2024. doi:10.1007/s00277-024-05803-y

BibTeX
@article{Guarnera2024,
  author = {Guarnera, Luca and Pascale, Maria Rosaria and Hajrullaj, Hajro and Cristiano, Antonio and Mallegni, Flavia and Onorato, Angelo and Voso, Maria Teresa and Fabiani, Emiliano},
  title = {The role of clonal progression leading to the development of therapy-related myeloid neoplasms},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05803-y}
}
Kostenlos starten →